| Financial Year |
March 31 2023 |
| Monetary Funds |
910,418,207.44 |
| Held-for-trading Financial Assets |
1,800,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,069,370,597.26 |
| Advances to Suppliers |
70,889,873.61 |
| Other Receivables |
131,528,934.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
680,082,760.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,159,409.05 |
| Other Current Assets |
49,546,951.79 |
| Total Current Assets |
2,915,545,174.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
329,801.30 |
| Long-term Equity Investment |
384,601,585.59 |
| Investment Properties |
85,439,656.67 |
| Fixed Assetes |
743,649,536.22 |
| Under-construction Projects |
17,768,640.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,468,921.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,554,986.10 |
| Deferred Income Tax Assets |
117,702,577.81 |
| Other Non-Current Assets |
22,611,455.04 |
| Sub-Total of Non-Current Assets |
1,622,669,253.03 |
| Total Assets |
4,538,214,427.86 |
| Short-Term Loans |
635,149,565.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
78,117,093.33 |
| Accounts Payable |
820,742,360.59 |
| Accounts Received In Advance |
2,098,275.25 |
| Employee Compensation Payable |
29,690,396.54 |
| Taxes Payable |
20,739,424.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
85,560,895.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
100,177,354.44 |
| Other Current Liabilities |
7,302,534.41 |
| Sub-Total of Current Liabilities |
1,884,875,529.69 |
| Long-term Loans |
507,638,457.86 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,637,609.07 |
| Deferred Income Tax Liabilities |
1,428,171.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
555,138,554.67 |
| Total Liabilities |
2,440,014,084.36 |
| Paid-In Capital(Or Share Stock) |
468,383,913.00 |
| Capital Surplus |
829,737,722.01 |
| Surplus Reserve |
158,700,394.70 |
| LESS:Treasury Stock |
247,900,506.13 |
| Undistributed Profits |
883,732,731.05 |
| Minority Stockholder's Interest |
2,993,847.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,095,206,496.33 |
| Owner's Equity（Stockholder's Equity） |
2,098,200,343.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,538,214,427.86 |
